Lisata Therapeutics (LSTA) Projected to Post Quarterly Earnings on Thursday

Lisata Therapeutics (NASDAQ:LSTA) is projected to issue its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.76) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Lisata Therapeutics Price Performance

NASDAQ LSTA opened at $2.41 on Wednesday. Lisata Therapeutics has a 1 year low of $2.19 and a 1 year high of $4.20. The stock has a market capitalization of $20.19 million, a PE ratio of -0.96 and a beta of 1.14. The company’s 50 day simple moving average is $2.97 and its two-hundred day simple moving average is $2.92.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and issued a $15.00 target price on shares of Lisata Therapeutics in a research note on Wednesday, December 11th.

Lisata Therapeutics Company Profile

Lisata Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease.